|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 3/02/20 Allscripts Healthcare Soluti… Inc 10-K 12/31/19 156:33M ActiveDisclosure/FA |
Document/Exhibit Description Pages Size
1: 10-K Annual Report HTML 3.26M
2: EX-4.5 Instrument Defining the Rights of Security Holders HTML 55K
3: EX-21.1 Subsidiaries List HTML 60K
4: EX-23.1 Consent of Experts or Counsel HTML 45K
5: EX-31.1 Certification -- §302 - SOA'02 HTML 51K
6: EX-31.2 Certification -- §302 - SOA'02 HTML 51K
7: EX-32.1 Certification -- §906 - SOA'02 HTML 47K
30: R1 Document and Entity Information HTML 109K
90: R2 Consolidated Balance Sheets HTML 171K
145: R3 Consolidated Balance Sheets (Parenthetical) HTML 69K
51: R4 Consolidated Statements of Operations HTML 178K
31: R5 Consolidated Statements of Comprehensive Income HTML 82K
92: R6 Consolidated Statements of Stockholders' Equity HTML 146K
146: R7 Consolidated Statements of Stockholders' Equity HTML 46K
(Parenthetical)
49: R8 Consolidated Statements of Cash Flows HTML 189K
34: R9 Basis of Presentation and Significant Accounting HTML 130K
Policies
115: R10 Revenue from Contracts with Customers HTML 282K
137: R11 Leases HTML 164K
74: R12 Business Combinations and Other Investments HTML 196K
22: R13 Fair Value Measurements HTML 209K
116: R14 Fixed Assets HTML 93K
138: R15 Goodwill and Intangible Assets HTML 300K
75: R16 Asset Impairment Charges HTML 70K
23: R17 Debt HTML 289K
120: R18 Income Taxes HTML 408K
136: R19 Stock Award Plan HTML 298K
56: R20 Stockholders' Equity HTML 55K
35: R21 Earnings (Loss) Per Share HTML 224K
86: R22 Accumulated Other Comprehensive Loss HTML 289K
140: R23 Derivative Financial Instruments HTML 197K
57: R24 Commitments HTML 57K
36: R25 Discontinued Operations HTML 178K
87: R26 Business Segments HTML 144K
141: R27 Supplemental Disclosures HTML 173K
55: R28 Geographic Information HTML 96K
40: R29 Contingencies HTML 59K
29: R30 Quarterly Financial Information (Unaudited) HTML 499K
80: R31 Schedule II-Valuation and Qualifying Accounts HTML 102K
133: R32 Basis of Presentation and Significant Accounting HTML 221K
Policies (Policies)
112: R33 Basis of Presentation and Significant Accounting HTML 96K
Policies (Tables)
28: R34 Revenue from Contracts with Customers (Tables) HTML 237K
79: R35 Leases (Tables) HTML 165K
132: R36 Business Combinations and Other Investments HTML 186K
(Tables)
111: R37 Fair Value Measurements (Tables) HTML 207K
24: R38 Fixed Assets (Tables) HTML 95K
81: R39 Goodwill and Intangible Assets (Tables) HTML 301K
43: R40 Asset Impairment Charges (Tables) HTML 65K
60: R41 Debt (Tables) HTML 262K
156: R42 Income Taxes (Tables) HTML 414K
100: R43 Stock Award Plan (Tables) HTML 298K
42: R44 Earnings (Loss) Per Share (Tables) HTML 225K
59: R45 Accumulated Other Comprehensive Loss (Tables) HTML 291K
155: R46 Derivative Financial Instruments (Tables) HTML 197K
99: R47 Commitments (Tables) HTML 55K
41: R48 Discontinued Operations (Tables) HTML 183K
62: R49 Business Segments (Tables) HTML 138K
68: R50 Supplemental Disclosures (Tables) HTML 179K
13: R51 Geographic Information (Tables) HTML 100K
108: R52 Quarterly Financial Information (Unaudited) HTML 499K
(Tables)
127: R53 Basis of Presentation and Significant Accounting HTML 64K
Policies - Additional Information (Detail)
69: R54 Basis of Presentation and Significant Accounting HTML 50K
Policies - Unamortized Balances of Capitalized
Software (Detail)
14: R55 Basis of Presentation and Significant Accounting HTML 51K
Policies - Capitalized Software Development Costs,
Write Offs and Amortization of Capitalized
Software Development Costs (Detail)
110: R56 Basis of Presentation and Significant Accounting HTML 46K
Policies - Company Contributions to Employee
Benefit Plan (Detail)
128: R57 Revenue from Contracts with Customers - Additional HTML 70K
Information (Detail)
67: R58 Revenue from Contracts with Customers - Summary of HTML 60K
Revenue Recognized on Various Performance
Obligations and Elected Accounting Expedients
(Detail)
15: R59 Revenue from Contracts with Customers - Summary of HTML 83K
Revenue by Type and Nature of Revenue Stream by
Reportable Segments (Detail)
93: R60 Leases - Additional Information (Detail) HTML 60K
151: R61 Leases - Summary of Total Costs Associated with HTML 61K
Leased Assets (Detail)
63: R62 Leases - Supplemental Information for Operating HTML 58K
and Finance Leases (Detail)
44: R63 Leases - Summary of Balance Sheet Location and HTML 89K
Balances for Operating and Finance Leases (Detail)
96: R64 Leases - Summary of Future Maturities of Lease and HTML 91K
Non-Lease Components (Detail)
154: R65 Business Combinations and Other Investments - HTML 64K
Additional Information (Detail)
66: R66 Business Combinations and Other Investments - HTML 71K
Acquisition of Health Grid - Additional
Information (Detail)
47: R67 Business Combinations and Other Investments - HTML 69K
Schedule of Consideration Transaction (Detail)
97: R68 Business Combinations and Other Investments - HTML 87K
Assets Acquired and Liabilities Assumed (Detail)
149: R69 Business Combinations and Other Investments - HTML 69K
Acquired Intangible Assets Amortization (Detail)
124: R70 Business Combinations and Other Investments - HTML 59K
Acquisition of Practice Fusion, Inc - Additional
Information (Detail)
107: R71 Business Combinations and Other Investments - HTML 55K
Netsmart LLC Divestiture - Additional Information
(Detail)
19: R72 Business Combinations and Other Investments - HTML 133K
Other Acquisitions, Divestitures and Investments -
Additional Information (Detail)
73: R73 Business Combinations and Other Investments - HTML 64K
Summary of Other Equity Investments Included in
Other Assets (Detail)
121: R74 Business Combinations and Other Investments - HTML 59K
Impairment of and Losses on Long-term Investments
- Additional Information (Detail)
103: R75 Fair Value Measurements - Additional Information HTML 53K
(Detail)
16: R76 Fair Value Measurements - Summary of Financial HTML 94K
Assets and Liabilities Measured at Fair Value on
Recurring Basis (Detail)
70: R77 Fair Value Measurements - Summary of Financial HTML 50K
Assets and Liabilities Measured at Fair Value on
Recurring Basis (Parenthetical) (Detail)
126: R78 Fair Value Measurements - Summary of Changes in HTML 74K
Assets and Liabilities Measured at Fair Value on
Recurring Basis (Detail)
102: R79 Fair Value Measurements - Summary of Changes in HTML 50K
Assets and Liabilities Measured at Fair Value on
Recurring Basis (Parenthetical) (Detail)
123: R80 Fixed Assets - Fixed Assets (Detail) HTML 76K
106: R81 Fixed Assets - Additional Information (Detail) HTML 49K
18: R82 Fixed Assets - Depreciation and Amortization HTML 47K
Expense (Detail)
72: R83 Goodwill and Intangible Assets - Goodwill and HTML 65K
Intangible Assets (Detail)
122: R84 Goodwill and Intangible Assets - Additional HTML 91K
Information (Detail)
105: R85 Goodwill and Intangible Assets - Changes in HTML 123K
Carrying Amount of Goodwill (Detail)
17: R86 Goodwill and Intangible Assets - Amortization HTML 52K
Expense Related to Intangible Assets (Detail)
71: R87 Goodwill and Intangible Assets - Future HTML 61K
Amortization Expense for Intangible Assets
(Detail)
125: R88 Asset Impairment Charges - Additional Information HTML 92K
(Detail)
101: R89 Asset Impairment Charges - Summary of Non-Cash HTML 56K
Asset Impairment Charges (Detail)
94: R90 Debt - Debt Outstanding Excluding Finance Lease HTML 78K
Obligations (Detail)
152: R91 Debt - Interest Expense (Detail) HTML 59K
64: R92 Debt - Interest Expense Related to 0.875% HTML 53K
Convertible Senior Notes and 1.25% Cash
Convertible Senior Notes (Detail)
45: R93 Debt - Additional Information (Detail) HTML 275K
95: R94 Debt - Summary of Future Debt Payments (Detail) HTML 83K
153: R95 Debt - Summary of Future Debt Payments HTML 48K
(Parenthetical) (Detail)
65: R96 Income Taxes - Geographic Breakdown of (Loss) HTML 56K
Income Before Income Tax Benefits (Detail)
46: R97 Income Taxes - Components of (Benefit) Provision HTML 78K
for Income Taxes (Detail)
98: R98 Income Taxes - Additional Information (Detail) HTML 128K
150: R99 Income Taxes - Taxes Computed at Statutory Federal HTML 112K
Income Tax Rate Reconciled to Provision for Income
Taxes (Detail)
26: R100 Income Taxes - Components of Deferred Tax Assets HTML 97K
and Liabilities (Detail)
83: R101 Income Taxes - Deferred Tax Assets (Liabilities) HTML 54K
Classified in Consolidated Balance Sheets (Detail)
131: R102 Income Taxes - Change in the Amount of HTML 63K
Unrecognized Tax Benefits (Detail)
114: R103 Income Taxes - Recognized Interest and Penalties HTML 46K
Related to Uncertain Tax Positions (Detail)
25: R104 Income Taxes - Amount of Interest and Penalties HTML 46K
Included in Consolidated Balance Sheets (Detail)
82: R105 Stock Award Plan - Stock-Based Compensation HTML 60K
Expense (Detail)
129: R106 Stock Award Plan - Additional Information (Detail) HTML 108K
113: R107 Stock Award Plan - Activity for Restricted Stock HTML 71K
Units (Detail)
27: R108 Stock Award Plan - Stock Options Outstanding HTML 76K
(Detail)
78: R109 Stock Award Plan - Stock Option Activity (Detail) HTML 49K
53: R110 Stock Award Plan - Stock Option Awards (Detail) HTML 70K
38: R111 Stockholders' Equity - Additional Information HTML 131K
(Detail)
84: R112 Earnings (Loss) Per Share - Calculations of HTML 136K
Earnings (Loss) Per Share (Detail)
142: R113 Earnings (Loss) Per Share - Anti-Dilutive Stock HTML 47K
Options, Restricted Stock Unit Awards and Warrants
Excluded from Computation of Diluted Earnings
(Loss) Per Share (Detail)
54: R114 Accumulated Other Comprehensive Loss - Components HTML 75K
of Accumulated Other Comprehensive Loss (Detail)
39: R115 Accumulated Other Comprehensive Loss - Components HTML 52K
of Accumulated Other Comprehensive Loss
(Parenthetical) (Detail)
85: R116 Accumulated Other Comprehensive Loss - Income Tax HTML 127K
Effects Related to Components of Other
Comprehensive Loss (Detail)
143: R117 Accumulated Other Comprehensive Loss - Income Tax HTML 47K
Effects Related to Components of Other
Comprehensive Loss (Parenthetical) (Detail)
58: R118 Derivative Financial Instruments - Fair Value and HTML 68K
Balance Sheet Locations - (Detail)
37: R119 Derivative Financial Instruments - Additional HTML 71K
Information (Detail)
118: R120 Derivative Financial Instruments - Derivatives HTML 60K
Instruments Designated as Cash Flow Hedges -
(Detail)
134: R121 Derivative Financial Instruments - Net Impact of HTML 52K
Changes in Fair Value of Call Option and Embedded
Cash Conversion Option - (Detail)
76: R122 Commitments - Additional Information (Detail) HTML 47K
20: R123 Commitments - Summary of Expense Incurred under HTML 52K
Atos Agreement (Detail)
119: R124 Discontinued Operations - Additional Information HTML 57K
(Detail)
135: R125 Discontinued Operations - Summary of Major Income HTML 104K
and Expense Line Items Reported in Consolidated
Statements of Operations (Detail)
77: R126 Discontinued Operations - Summary of Major Classes HTML 88K
of Line Items Constituting Income (Loss) of
Discontinued Operations (Detail)
21: R127 Business Segments - Additional Information HTML 47K
(Detail)
117: R128 Business Segments - Revenues and Income from HTML 69K
Operations Related to Segment Within
Reconciliation to Consolidated Amounts (Detail)
139: R129 Supplemental Disclosures - Supplemental HTML 81K
Disclosures (Detail)
148: R130 Supplemental Disclosures - Accrued Expenses HTML 58K
(Detail)
89: R131 Supplemental Disclosures - Additional Information HTML 45K
(Detail)
33: R132 Supplemental Disclosures - Prepaids and Other HTML 52K
Current Assets (Detail)
50: R133 Supplemental Disclosures - Other Assets (Detail) HTML 64K
147: R134 Supplemental Disclosures - Other Assets HTML 47K
(Parenthetical) (Detail)
88: R135 Geographic Information - Revenues by Geographic HTML 59K
Area (Detail)
32: R136 Geographic Information - Long-Lived Assets by HTML 58K
Geographic Area (Detail)
48: R137 Contingencies - Additional Information (Detail) HTML 60K
144: R138 Quarterly Financial Information (Unaudited) - HTML 179K
Quarterly Financial Information (Unaudited)
(Detail)
91: R139 Schedule II - Valuation And Qualifying Accounts HTML 53K
(Detail)
52: XML IDEA XML File -- Filing Summary XML 308K
61: XML XBRL Instance -- mdrx-10k_20191231_htm XML 9.49M
104: EXCEL IDEA Workbook of Financial Reports XLSX 199K
9: EX-101.CAL XBRL Calculations -- mdrx-20191231_cal XML 487K
10: EX-101.DEF XBRL Definitions -- mdrx-20191231_def XML 1.48M
11: EX-101.LAB XBRL Labels -- mdrx-20191231_lab XML 2.60M
12: EX-101.PRE XBRL Presentations -- mdrx-20191231_pre XML 2.33M
8: EX-101.SCH XBRL Schema -- mdrx-20191231 XSD 377K
109: JSON XBRL Instance as JSON Data -- MetaLinks 690± 1.17M
130: ZIP XBRL Zipped Folder -- 0001564590-20-008173-xbrl Zip 612K
Exhibit 31.1
CERTIFICATION
I, Paul M. Black, certify that:
|
1. |
I have reviewed this Annual Report on Form 10-K of Allscripts Healthcare Solutions, Inc.; |
|
2. |
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
|
3. |
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
|
4. |
The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
|
|
a. |
designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
|
|
b. |
designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
|
|
c. |
evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
|
|
d. |
disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and |
|
5. |
The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's Board of Directors (or persons performing the equivalent functions): |
|
|
a. |
all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting, which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and |
|
|
b. |
any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting. |
|
|
|
|
|
Date: March 2, 2020 |
|
/s/ Paul M. Black |
|
|
|
Chief Executive Officer |
| This ‘10-K’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 3/2/20 | 8-K | ||
| For Period end: | 12/31/19 | |||
| List all Filings | ||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 5/28/20 SEC UPLOAD¶ 6/25/20 2:39K Veradigm Inc. 5/07/20 SEC UPLOAD¶ 6/25/20 2:44K Veradigm Inc. |